Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
Dte4MSq8rhgaDZ8Y